Recent News

• 06.12.2025 - Incannex Healthcare Cancels All Outstanding Series A Warrants Following Strategic ATM Execution
• 06.03.2025 - Incannex Healthcare Inc. Expands IHL-42X Clinical Advisory Board with Appointments of Four Industry and Academic Leaders to Advance Obstructive Sleep Apnea (OSA) Program
• 05.29.2025 - Incannex Healthcare Inc. Advances IHL-42X RePOSA Trial to Phase 3 Following FDA Protocol Clearance
• 05.28.2025 - Incannex Healthcare Inc. Enters Agreement to Cancel Remaining Series A Warrants, Eliminating Up to 347.2 Million Shares from Potential Dilution Ahead of IHL-42X Phase 2 Topline Results
• 05.20.2025 - Incannex Healthcare Inc. Executes Strategic Cancellation of 50.4% of Series A Warrants, Significantly Reducing Potential Dilution
• 05.16.2025 - Incannex Announces Potential Reduction of Up to 50.4% of its Series A Warrants

Recent Filings

• 06.04.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 06.03.2025 - 8-K Current report
• 06.03.2025 - EX-99.1 EX-99.1
• 05.29.2025 - EX-99.1 EX-99.1
• 05.29.2025 - 8-K Current report
• 05.28.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 05.28.2025 - 8-K Current report
• 05.28.2025 - EX-99.1 EX-99.1
• 05.28.2025 - 8-K Current report
• 05.20.2025 - 424B5 Prospectus [Rule 424(b)(5)]